EyePoint, Inc. Unrealized Gain (Loss) on Derivatives
EyePoint, Inc. (EYPT) reported Unrealized Gain (Loss) on Derivatives of $170.00 thousand for the 12-month period ending 2012-06-30, per its 10-K filed 2014-09-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2014-09-11
- EyePoint, Inc. unrealized gain (loss) on derivatives for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. unrealized gain (loss) on derivatives for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. unrealized gain (loss) on derivatives for the quarter ending 2011-12-31 was $128.00K, a 72.05% decline year-over-year.
- EyePoint, Inc. unrealized gain (loss) on derivatives for the quarter ending 2011-09-30 was $42.00K, a 87.57% decline year-over-year.
- EyePoint, Inc. unrealized gain (loss) on derivatives for fiscal 2012 was $170.00K, a 85.09% decline from fiscal 2011.
- EyePoint, Inc. unrealized gain (loss) on derivatives for fiscal 2011 was $1.14M.
- EyePoint, Inc. unrealized gain (loss) on derivatives for fiscal 2010 was -$339.00K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2012-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11 | $0.00 derived: sum of 2 quarters · filed 2014-09-11 | $128.00K derived: sum of 3 quarters · filed 2014-09-11 | $170.00K 10-K · filed 2014-09-11 |
| 2012-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-14 | $128.00K derived: sum of 2 quarters · filed 2013-05-14 | $170.00K 10-Q · filed 2013-05-14 | $180.00K derived: sum of 4 quarters · filed 2013-09-27 |
| 2011-12-31 | $128.00K 10-Q · filed 2013-02-08 | $170.00K 10-Q · filed 2013-02-08 | $180.00K derived: sum of 3 quarters · filed 2013-09-27 | $514.00K derived: sum of 4 quarters · filed 2013-09-27 |
| 2011-09-30 | $42.00K 10-Q · filed 2012-11-09 | $52.00K derived: sum of 2 quarters · filed 2013-09-27 | $386.00K derived: sum of 3 quarters · filed 2013-09-27 | $844.00K derived: sum of 4 quarters · filed 2013-09-27 |
| 2011-06-30 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27 | $344.00K derived: sum of 2 quarters · filed 2013-09-27 | $802.00K derived: sum of 3 quarters · filed 2013-09-27 | $1.14M 10-K · filed 2013-09-27 |
| 2011-03-31 | $334.00K 10-Q · filed 2012-05-10 | $792.00K derived: sum of 2 quarters · filed 2012-05-10 | $1.13M 10-Q · filed 2012-05-10 | |
| 2010-12-31 | $458.00K 10-Q · filed 2012-02-09 | $796.00K 10-Q · filed 2012-02-09 | ||
| 2010-09-30 | $338.00K 10-Q/A · filed 2011-11-09 | |||
| 2010-06-30 | -$339.00K 10-K · filed 2012-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |